Top 5 Myths About Meningitis

22nd January 2015

Knowing the signs of meningitis can save your life. Here are the five most common myths about meningitis 

Top five meningitis myths letterbox

1. Only babies get meningitis

WRONGMeningitis can affect anyone.

2. You always get a rash with meningitis

WRONGA rash is a sign of blood poisoning (septicaemia*) and it can be one of the last symptoms to be displayed. If and when it does, it could be too late.

*Many medical experts now use the term sepsis instead of septicaemia

3. All types of meningitis can be prevented with vaccines

WRONGThere is NO vaccine to protect against all forms of meningitis, Familiarise yourself with the signs and symptoms.

4. Meningitis is always fatal 

WRONG: 10% of people who contract bacterial meningitis will die. We also estimate that up to 30%-50% of those who survive bacterial meningitis are left with one or more permanent problems such as hearing loss, learning and behavioural problems and epilepsy.

Find out more about symptoms.

5. Viral meningitis is a mild form of the disease

WRONG: Although it’s rarely life-threatening, viral meningitis can leave people with serious and debilitating after-effects, including headaches and memory loss.

Download a signs and symptoms card, be aware and trust your instincts.

  • Michelle and Stuart bacterial meningitis case study

    Support for Michelle after losing her husband

    Two years after the death of husband Stuart, Michelle Jackson spoke to us about the help she got and why she would encourage others to reach out

  • Kye's new bionic arms

    Kye's new bionic arms

    One of our young supporters has been fitted with a special new cover for his bionic arm – featuring iconic Star Wars character R2D2

  • Helen D Rebuilding Futures Fund

    Helping Helen get around at home

    Our Rebuilding Futures Fund was available to provide a practical solution to improve Helen's independence – a small indoor powered wheelchair

  • Meningitis Now research

    Trial to prevent Group B Strep

    We welcome a landmark clinical trial aiming to improve the prevention of the potentially life-threatening infection in newborn babies